Evidence map›Paper›PMID 19490325›Full record

ArticleJournal of food science

Purification and use of glycomacropeptide for nutritional management of phenylketonuria.

Caitlin E Laclair, Denise M Ney, Erin L MacLeod, Mark R Etzel

Registry-linked trialAbstract read
In one paragraph

Article in Journal of food science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01428258 (Phase 2 Study of Glycomacropeptide vs. Amino Acid Diet for the Management of PKU), which is not on this map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01428258 nacompletednot on this map

Phase 2 Study of Glycomacropeptide vs. Amino Acid Diet for the Management of PKU

TypeinterventionalSponsorUniversity of Wisconsin, MadisonRan2011 to 2016Enrolled32ConditionsPhenylketonuriaArmsGMP Diet/GMP Medical Foods, AA Diet/AA Medical Foods
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Caitlin E LaclairDept. of Food Science, Univ. of Wisconsin, Madison, WI 53706, USA.
Denise M Ney
Erin L MacLeod
Mark R Etzel
University of Wisconsin–Madison · US

Funding

WISCONSIN CENTER ON MENTAL RETARDATION: CORE SUPPORTP30HD003352 · NICHD · UNIVERSITY OF WISCONSIN-MADISON · PI MESSING, ALBEE · 1985 to 2015
$25.2M
Dietary Control of PKU with Glycomacropeptide from WheyR03DK071534 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI NEY, DENISE M · 2005 to 2007
$308k
NICHD NIH HHS P30 HD003352NICHD NIH HHS P30-HD-03352NIDDK NIH HHS R03 DK071534NIDDK NIH HHS R03-DK-071534
6 · The paper itself

Abstract

Individuals with phenylketonuria (PKU) cannot metabolize phenylalanine (Phe) and must adhere to a low-Phe diet in which most dietary protein is provided by a Phe-free amino acid formula. Glycomacropeptide (GMP) is the only naturally occurring protein that does not contain Phe, and is of interest as a source of protein for dietary management of PKU. However, commercially available GMP contains too much Phe from residual whey proteins and does not contain adequate levels of all the indispensable amino acids to provide a nutritionally complete protein. The aim of this study was to increase purity of GMP and develop a mass balance calculation for indispensable amino acid supplementation of GMP foods. Cation exchange chromatography, ultrafiltration/diafiltration, and lyophilization were used at the pilot plant scale to decrease Phe. Enough purified GMP (5 kg) was manufactured to provide 15 PKU subjects with a 4-d diet in which the majority of protein was from GMP foods. A mass balance was used to supplement GMP foods so that all indispensable amino acids met or exceeded the daily recommended intake. GMP foods were tested in a human clinical trial as a replacement for the traditional amino acid formula. Nutritionally complete GMP foods created with high purity GMP provide individuals with PKU with more options to manage PKU, which may lead to improved compliance and quality of life.

Indexed as

Amino AcidsAnimalsCaseinsChromatography, Ion ExchangeFreeze DryingHumansLysineMilkNutritional RequirementsPeptide FragmentsPhenylalaninePhenylketonuriasUltrafiltrationAmino AcidscaseinomacropeptideCaseinsLysinePeptide FragmentsPhenylalanine

Identifiers

PMID19490325
PMCPMC3632067
OpenAlexW2020410227

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.